BRL29060A (Paroxetine Hydrochloride Hydrate) in Posttraumatic Stress Disorder

Clinical trial NCT00839397 · COMPLETED

Trial details

NCT number: NCT00839397
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Post-Traumatic Stress Disorder

Start date: 2002-05-01
Primary completion: 2004-11-01
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.